Friday, November 9, 2012

Lung Cancer Awareness Month

(Google Image)

By Terry Orr

(Former Smoker)

Sadly, but true, I was a heavy smoker for far more
years that I’d like to admit – and quick cold-turkey walking back to work after
lunch with my good friend Ron Ziegler who asked me when are you going to quit. I said right now – and tossed my cigarettes
and lighter into the trash can on the sidewalk.
That day was March 31, 1987 and I have not had once since then. About 12 years later, my doctor and I were
discussing my recent chest x-ray which still depicted scar tissues from all
that smoking. Happily – my lungs today
are clear. Thanks Z and happy birthday.

(Google Image)

What Is Lung Cancer?

Lung canceris the uncontrolled growth of abnormal cells that start
off in one or both lungs; usually in the cells that line the air passages. The
abnormal cells do not develop into healthy lung tissue; they divide rapidly and
form tumors. As tumors become larger and more numerous, they undermine the
lung’s ability to provide the bloodstream with oxygen.

Although lung cancer is the leading cause of cancer death in the U.S. in
both men and women,it is also one of the most preventable kinds of cancer. At least four out of five
cases are associated with cigarette smoking, and the cause-and-effect
relationship has been extensively documented. (Source:
WebMD)

(Google Image)

What
are the key statistics about lung cancer?

Lung cancer (both small cell and non-small cell) is the
second most common cancer in both men and women (not counting skin cancer). In
men, prostate cancer is more common, while in women breast cancer is more
common. Lung cancer accounts for about 14% of all new cancers.

(Google Image)

The American Cancer Society's most recent estimates for
lung cancer in the United States are for 2012:

About 226,160 new cases of lung
cancer will be diagnosed (116,470 in men and 109,690 in women).

There will be an estimated 160,340
deaths from lung cancer (87,750 in men and 72,590 among women), accounting for
about 28% of all cancer deaths.

Lung cancer is by far the leading cause of
cancer death among both men and women.

Each year, more people die of lung cancer than
of colon, breast, and prostate cancers combined.

Lung cancer mainly occurs in older
people. About 2 out of 3 people diagnosed with lung cancer are 65 or older;
fewer than 2% of all cases are found in people younger than 45. The average age
at the time of diagnosis is about 71.

Overall, the chance that a man will
develop lung cancer in his lifetime is about 1 in 13; for a woman, the risk is
about 1 in 16. These numbers include both smokers and non-smokers. For smokers
the risk is much higher, while for non-smokers the risk is lower.

(Google Image)

Lung Cancer
Causes

Cigarette smoking is the most important cause of lung
cancer. Research as far back as the 1950s clearly established this relationship.

About 90% of lung cancers arise due to tobacco use. The
risk of developing lung cancer is related to the following factors:

The
number of cigarettes smoked

The age
at which a person started smoking

How
long a person has smoked (or had smoked before quitting)

Other causes of lung cancer, including causes of lung
cancer in nonsmokers, include the following:

Lung diseases,
such as tuberculosis (TB) and chronic obstructive pulmonary disease (COPD),
also create a risk for lung cancer.

Radon
exposure poses another risk.

Certain
occupations where exposure to arsenic, chromium, nickel, aromatic hydrocarbons,
and ethers occurs may increase the risk of lung cancer.

A
person who has had lung cancer is more likely to develop a second lung cancer
than the average person is to develop a first lung cancer.

(Google Image)

Lung Cancer
Treatment

There are four basic ways to treat lung cancer: surgery,
radiation therapy, chemotherapy, and targeted therapy.

Surgery

A surgical oncologist is a doctor who specializes in
treating cancer using surgery. For lung cancer, a thoracic surgeon is specially
trained to perform lung cancer surgery. The goal of surgery is the complete
removal of the lung tumor and the nearby lymph nodes in the chest. The tumor
must be removed with a surrounding border of normal lung tissue (called the
margin).

The following types
of surgery may be used for lung cancer:

Lobectomy. The lungs have five lobes, three in the right lung and
two in the left lung.

A wedge. If the surgeon cannot remove an entire lobe of the lung,
the surgeon can remove the tumor, surrounded by a margin of normal lung.

Pneumonectomy. If the tumor is close to the center of the chest, the surgeon
may have to remove the entire lung.

Radiofrequency
ablation. Radiofrequency
ablation (RFA) is the use of a needle inserted into the tumor to destroy the
cancer with an electrical current.

Adjuvant
therapy

Adjuvant therapy is treatment that is given after surgery to lower the
risk of the lung cancer returning. Adjuvant therapy includes radiation therapy,
chemotherapy, and possibly targeted therapy.

Radiation therapyis the use of high energy x-rays or other particles to
kill cancer cells.

Chemotherapy is the
use of drugs to kill cancer cells, usually by stopping the cancer cells'
ability to grow and divide.

Targeted therapyis a treatment that targets the cancer's specific genes,
proteins, or the tissue environment that contributes to cancer growth and
survival. This type of treatment blocks the growth and spread of cancer cells
while limiting damage to normal cells.

Anti-angiogenesis
therapyis focused on stopping angiogenesis, which
is the process of making new blood vessels. Because a tumor needs the nutrients
delivered by blood vessels to grow and spread, the goal of anti-angiogenesis
therapies is to “starve” the tumor.

Epidermal growth
factor receptor (EGFR) inhibitors.Researchers have
found that drugs that block EGFR may be effective in stopping or slowing the
growth of lung cancer.

Cetuximab (Erbitux)is an EGFR inhibitor given along with chemotherapy to
treat lung cancer, especially when treatment with bevacizumab is not
recommended. It is given intravenously.

Erlotinib (Tarceva)is another drug that blocks the EGFR. This drug has been
shown to work better than chemotherapy if the lung cancer has a mutation
(change) in the EGFR gene.

Gefitinib (Iressa) is
another drug that blocks the EGFR. In the United States, it is available only
to people who were already taking it, had taken it in the past and had a good
effect, or as part of a clinical trial.